EcoDrugPlus

Bcl-2-Like Protein 1

Ensembl ID : ENSCVAG00000010251
Gene Symbol: LOC107102478
3 Cross references
229 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSCVAG00000018454
Gene Symbol: LOC107086315
3 Cross references
196 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCVAG00000016059
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSCVAG00000000469
Gene Symbol: BDKRB1
1 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCVAG00000016860
Gene Symbol: BDKRB2
1 Cross references
240 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCVAG00000016814
Gene Symbol: BDKRB2
4 Cross references
182 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCVAG00000016836
Gene Symbol: BDKRB2
1 Cross references
219 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCVAG00000016818
Gene Symbol: BDKRB2
3 Cross references
240 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSCVAG00000007809
Gene Symbol: LOC107082622
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSCVAG00000018147
Gene Symbol: LOC107105244
3 Cross references
179 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSCVAG00000013999
Gene Symbol: LOC107083082
2 Cross references
187 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSCVAG00000009929
Gene Symbol: LOC107104416
3 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).